SG Americas Securities, LLC
Broker-DealerPosition in ASND — Ascendis Pharma A/S
CIK 1313360
NEW YORK, NY
Position in ASND
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$42,948,854
+$15,320,558 QoQ
Shares Held
161,026
+33.3% QoQ
Ownership
0.245%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#50
of 307 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SG Americas Securities, LLC holds $1,085,838,933 across 181 Biotechnology names. ASND ranks #6 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
427,703 | $266,689,928 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
523,720 | $260,147,435 | |
| 3 | URGN |
UroGen Pharma Ltd.
|
2,052,906 | $75,546,940 | |
| 4 | CGON |
CG Oncology, Inc.
|
867,465 | $61,633,388 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
605,581 | $49,397,242 | |
| 6 | ASND |
Ascendis Pharma A/S
This page
|
161,026 | $42,948,854 | |
| 7 | RPRX |
Royalty Pharma plc
|
688,590 | $38,609,241 | |
| 8 | BNTX |
BioNTech SE
|
347,131 | $32,300,539 |
All Filings in ASND
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,948,854 | 161,026 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $27,628,296 | 120,790 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $2,391,060 | 11,213 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $530,822 | 2,670 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $2,919,529 | 16,915 | Shares | Sole | 2025-08-08 | |
| 2024-12-31 | $4,673,070 | 33,944 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $331,617 | 2,221 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $833,009 | 6,108 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $287,676 | 1,903 | Shares | Sole | 2024-05-06 | |
| 2023-03-31 | $4,969,325 | 46,347 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $2,556,180 | 20,930 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $112,759 | 1,092 | Shares | Sole | 2022-10-31 | |
| 2022-03-31 | $110,553 | 942 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $107,624 | 800 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $518,655 | 3,254 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $332,426 | 2,527 | Shares | Sole | 2021-08-12 | |
| 2020-12-31 | $328,723 | 1,971 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $180,091 | 1,167 | Shares | Sole | 2020-11-09 | |
| 2020-03-31 | $249,205 | 2,213 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||